138 Results

People

  1. Ulaner
    Ulaner
  2. Hudis
    Hudis
  3. Modi
    Modi
  4. Jhaveri
    Jhaveri
  5. Jochelson
    Jochelson
  6. Schoder
    Schoder
  7. Larson
    Larson
  8. Solit
    Solit
  9. Drullinsky
    Drullinsky
  10. Patil
    Patil

Groups

  1. Breast Medicine Service (138)
  2. Department of Medicine (138)
  3. Molecular Imaging and Therapy Service (138)
  4. Solid Tumor Oncology Division (138)
  5. Radiology, Department of (131)
  6. Survivorship Research (79)
  7. GSK Faculty (73)
  8. Epidemiology and Biostatistics (68)
  9. Biostatistics Service (57)
  10. Population Sciences Research Program (45)
  1. "Molecular Imaging and Therapy Service"
  2. "Breast Medicine Service"
Formats
  1. Journal Article (77)
  2. Meeting Abstract (60)
  3. Review (1)
Groups
  1. Breast Medicine Service (138)
  2. Department of Medicine (138)
  3. Molecular Imaging and Therapy Service (138)
  4. Solid Tumor Oncology Division (138)
  5. Radiology, Department of (131)
  6. Survivorship Research (79)

More Groups

People
  1. Gary Ulaner (36)
  2. Steven Larson (33)
  3. Clifford Hudis (30)
  4. Shanu Modi (30)
  5. Komal Jhaveri (29)
  6. Maxine Jochelson (28)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (6)
  4. 2021 (8)
  5. 2020 (12)
  6. 2019 (21)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Cancer Research (15)
  3. Journal of Nuclear Medicine (12)
  4. Blood (8)
  5. Clinical Cancer Research (8)
  6. Breast Cancer Research and Treatment (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. American Association for Cancer Research (26)
  3. Society of Nuclear Medicine (12)
  4. Springer (10)
  5. Wiley Blackwell (9)
  6. American Society of Hematology (8)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save
  • Predictive value of positron emission tomography/computed tomography to assess early treatment response to dual human epidermal growth factor receptor 2 (HER2) blockade without chemotherapy for HER2-positive metastatic breast cancer: Are we ready to embrace this "early metabolic look" strategy?
    Journal Article

    Jhaveri, K.; Ulaner, G. A.; Dickler, M. N.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Appearance of untreated bone metastases from breast cancer on FDG PET/CT: Importance of histologic subtype
    Journal Article

    Dashevsky, B. Z.; Goldman, D. A.; Parsons, M.; Gönen, M.; Corben, A. D.; Jochelson, M. S.; Hudis, C. A.; Morrow, M.; Ulaner, G. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Journal Article

    Jochelson, M. S.; Lampen Sachar, K.; Gibbons, G.; Dang, C.; Lake, D.; Morris, E. A.; Morrow, M.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I, open-label study evaluating the safety and tolerability of LJM716, BYL719 and trastuzumab in patients with metastatic HER2+ breast cancer
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Ulaner, G.; Zamora, S.; Sterlin, V.; Iasonos, A.; Dickler, M. N.; Moynahan, M. E.; Hudis, C. A.; Baselga, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A Markov chain model of a longitudinal breast cancer data set
    Meeting Abstract

    Newton, P. K.; Nieva, J. J.; Kuhn, P.; Norton, L.; Comen, E. A.; Mason, J.; Venkatappa, N.; Jochelson, M. S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save